BioRestorative Therapies Unveils MSC Exosome Proteomics from Cord, Adipose, Bone Marrow Enabling Targeted Regenerative, Aesthetic Applications
Preclinical proteomic analyses reveal that extracellular vesicles from umbilical cord, brown adipose tissue and bone marrow mesenchymal stem cells exhibit distinct protein signatures tied to regenerative signaling, immune modulation and epidermal barrier formation. These insights underpin development of targeted EV-based formulations for skin rejuvenation, scar repair, post-procedural recovery and hair health.
1. Preclinical Data Presentation
On May 6 at the ISCT 2026 Annual Meeting in Dublin, BioRestorative Therapies disclosed proteomic data demonstrating that extracellular vesicles sourced from umbilical cord, brown adipose tissue and bone marrow mesenchymal stem cells possess unique protein profiles.
2. Functional Pathway Insights
Gene ontology analysis identified enrichment in RNA/mRNA metabolic processes for regenerative signaling, cell adhesion and immune modulation pathways linked to wound healing, and keratinization/cornification pathways supporting epidermal barrier repair.
3. Applications for BioCosmeceutical Platform
The distinct functional signatures guide the design of EV-based formulations aimed at skin rejuvenation and anti-aging, post-procedural recovery, scar and wound repair, barrier hydration and hair and scalp health.
4. Integration into Development Strategy
BioRestorative plans to integrate these exosome capabilities across manufacturing, clinical validation and commercial operations, collaborating with key opinion leaders to advance next-generation regenerative and aesthetic products.